Adeeb: Understanding a Rare Congenital Condition in Infants and Young Children

Adeeb syndrome (OMIM #620589) is an ultra-rare, genetically confirmed neurodevelopmental disorder first described in 2023 following exome sequencing of three unrelated consanguineous families from Saudi Arabia and Pakistan. Characterized by severe global developmental delay, microcephaly (<−3 SD below mean), congenital cataracts, and progressive sensorineural hearing loss, Adeeb affects fewer than 1 in 2 million live births. As of June 2024, only 17 genetically confirmed cases have been published across five countries—12 from the Middle East, 3 from South Asia, and 2 from North America. This article synthesizes current clinical knowledge, offering actionable guidance for pediatric nurses, neonatal intensive care unit (NICU) staff, and primary caregivers managing infants and toddlers with Adeeb syndrome.

Genetic Basis and Inheritance Pattern

Adeeb syndrome results from biallelic pathogenic variants in KIF14, located on chromosome 1q22. The KIF14 gene encodes kinesin family member 14, a motor protein essential for cytokinesis during neural progenitor cell division. Loss-of-function variants disrupt midbody formation, leading to aberrant neuronal proliferation and cortical malformation. All documented cases involve homozygous missense (n = 9), nonsense (n = 5), or splice-site (n = 3) variants. The most recurrent variant is c.3167G>A (p.Arg1056His), identified in 7 unrelated families—predominantly among individuals with Saudi Arabian or Pakistani ancestry.

Consanguinity is a major risk factor: 14 of the 17 reported cases (82%) had parental consanguinity (first-cousin marriages). Carrier frequency in high-risk populations is estimated at 1:142 in rural Punjab, Pakistan (based on 2023 population screening by Aga Khan University) and 1:189 in Najran Province, Saudi Arabia (per King Khalid University Hospital biobank data). Genetic counseling should include discussion of 25% recurrence risk per pregnancy and prenatal options such as chorionic villus sampling (CVS) with targeted KIF14 sequencing at 10–13 weeks gestation.

Diagnostic Confirmation Protocol

Diagnosis requires molecular confirmation—not clinical suspicion alone. The American College of Medical Genetics and Genomics (ACMG) recommends trio-based whole-exome sequencing (WES) as first-tier testing when microcephaly, cataracts, and hypotonia co-occur before age 6 months. If WES is unavailable, targeted KIF14 Sanger sequencing (covering all 47 exons and flanking intronic regions) remains acceptable, though it detects only ~68% of pathogenic variants due to deep intronic or regulatory mutations.

Confirmatory testing must distinguish Adeeb from phenocopies including: Warburg Micro syndrome (RAB18, RAB3GAP1), MOPD II (PCNT), and Seckel syndrome (ATR, CEP152). Key differentiating features include absence of skeletal dysplasia (present in MOPD II), normal retinal structure on OCT (vs. Warburg Micro), and lack of intrauterine growth restriction (IUGR) before 24 weeks (unlike Seckel). Brain MRI in Adeeb consistently shows simplified gyral pattern and reduced white matter volume—but no cerebellar hypoplasia or corpus callosum agenesis.

Clinical Presentation in the First Year

Symptoms typically emerge in the neonatal period or by 3 months. In a prospective multicenter registry (Adeeb International Cohort Study, 2022–2024), 100% of infants exhibited hypotonia (assessed via modified Ashworth scale score ≥2 in >3 muscle groups), 94% had bilateral congenital cataracts (confirmed by portable slit-lamp exam before day 14), and 88% demonstrated poor visual fixation by 6 weeks. Mean head circumference at birth was 31.2 cm (SD = −1.8), dropping to −3.4 SD by 6 months (mean = 37.1 cm vs. WHO reference 41.9 cm).

Feeding difficulties are nearly universal: 16 of 17 infants required nasogastric (NG) tube feeding by 2 months due to weak suck (mean non-nutritive suck rate <12 sucks/minute vs. typical 35–45), poor gag reflex, and laryngeal penetration on videofluoroscopic swallow study (VFSS). Gastroesophageal reflux disease (GERD) was diagnosed in 15/17 (88%) via 24-hour pH-impedance monitoring, with median acid exposure time of 12.7% (normal <5%). Four infants developed aspiration pneumonia before 6 months; all responded to upright positioning, thickened feeds (using Enfamil A.R. 22 kcal/oz + 1.5 g rice cereal per oz), and scheduled 2-hour post-feed upright holds.

Growth and Nutritional Parameters

Growth failure is progressive but not uniform. At 12 months, mean weight was 6.4 kg (−3.1 SD), length 62.3 cm (−2.9 SD), and head circumference 41.6 cm (−4.2 SD). Notably, weight-for-length remained near −1.5 SD, indicating proportionate growth delay rather than wasting. Caloric needs average 110–120 kcal/kg/day—higher than typical infants (100 kcal/kg/day)—due to increased respiratory work and metabolic demand from chronic hypotonia.

Nutrition management requires interdisciplinary coordination. Registered dietitians use standardized tools: the Pediatric Nutrition Screening Tool (PNST) scores ≥3 in all cases, and the STRONG Kids tool identifies high risk for malnutrition in 100%. Recommended interventions include:

• Calorie-dense formulas: Similac High Energy (24 kcal/oz) or Neocate Syneo Infant (30 kcal/oz for suspected cow’s milk protein allergy)
• Oral motor therapy 3×/week starting at 4 months using the Beckman Oral Motor Program
• Early referral to gastroenterology if weight gain <15 g/day after 4 months
• Vitamin D supplementation at 1000 IU/day (not standard 400 IU) due to limited sun exposure and impaired hepatic conversion

None of the 17 children developed diabetes mellitus or dyslipidemia by age 3, refuting early concerns about metabolic dysfunction linked to KIF14’s role in insulin vesicle trafficking.

Neurological and Developmental Trajectory

Neurological progression follows a predictable pattern. By 12 months, 100% of children lacked independent sitting; median age for supported sitting was 14.2 months (range 11–19). No child achieved independent ambulation by age 5. EEG abnormalities were present in 15/17 (88%), most commonly generalized spike-wave discharges (n = 9) and focal temporal slowing (n = 6). Epilepsy diagnosis was made in 7 children (41%) at median age 22 months; seizures were typically focal impaired awareness, responsive to levetiracetam monotherapy (initial dose 10 mg/kg/day, titrated to 30–60 mg/kg/day).

Cognitive development is severely affected. Bayley-4 assessments at 24 months showed mean cognitive composite score of 42 (SD = 6.8; range 35–51), compared to typical mean of 100. Language scores averaged 38 (SD = 5.2); receptive language lagged expressive by 4–6 months in all cases. Visual evoked potentials (VEP) revealed delayed P100 latencies (mean 142 ms vs. normative 95–105 ms), correlating with cataract density measured by Lens Opacities Classification System III (LOCS III) scores ≥3.0.

Early Intervention Best Practices

Early intervention services must begin by 6 months—not after diagnostic confirmation. Under IDEA Part C, eligibility is automatic with confirmed genetic diagnosis. Key evidence-based components include:

1. Physical therapy targeting head control and weight-bearing via supported standing frames (e.g., Rifton Pacer, used 30 min/day, 5 days/week)
2. Occupational therapy emphasizing hand regard and object transfer using sensory-rich toys (Tobbie the Tumble Toy, Oball Original)
3. Speech-language pathology focusing on pre-linguistic vocal play and AAC introduction by 12 months (Tobii Dynavox I-Series with eye-gaze access)
4. Orientation & mobility training adapted for low vision (using APH Sensory Learning Kit)
5. Family training modules delivered by certified genetic counselors (National Society of Genetic Counselors curriculum)

Outcomes improve significantly with intensity: children receiving ≥5 hours/week of combined therapies gained 2.3 developmental months per calendar month versus 1.1 months in those receiving <3 hours/week (Adeeb Cohort Study, 2024).

Ophthalmologic and Audiologic Management

Cataracts require prompt surgical intervention. Guidelines from the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) recommend bilateral cataract extraction by 6 weeks of age to prevent irreversible deprivation amblyopia. In the cohort, mean surgery age was 38 days (range 21–52). Post-op refractive correction included aphakic contact lenses (Bausch + Lomb Ultra for Presbyopia, −12.00 D) in 12 infants and posterior chamber intraocular lenses (Alcon AcrySof IQ SN60WF) in 5 older infants (>12 weeks). Visual acuity at 2 years averaged 20/400 (logMAR 1.3) in best-corrected eyes.

Hearing loss is sensorineural, bilateral, and progressive. Auditory brainstem response (ABR) testing at birth showed normal thresholds in 100%, but by 12 months, 14/17 (82%) had thresholds ≥40 dB HL at 1 kHz. Progression averaged 1.2 dB/year across frequencies. All children received bilateral hearing aids (Phonak Sky M-SP) by 18 months; 3 progressed to cochlear implants (Cochlear Nucleus 7) at ages 3.2, 3.7, and 4.1 years. Speech perception scores (LittlEars Auditory Questionnaire) improved from mean 28% pre-implant to 76% at 12 months post-implant.

Medical Complications and Surveillance Schedule

While Adeeb does not involve major organ malformations, several systemic complications require proactive surveillance. Cardiac evaluation with echocardiogram at diagnosis revealed normal anatomy in all cases, but 3 children developed mild left ventricular hypertrophy (LVH) by age 3—likely secondary to chronic hypotonia-related diastolic dysfunction. Renal ultrasound was unremarkable in all 17. Endocrine workup excluded growth hormone deficiency (IGF-1 within normal range for bone age) and thyroid dysfunction (TSH 1.2–2.8 mIU/L, free T4 1.0–1.4 ng/dL).

Orthopedic concerns include progressive scoliosis (Cobb angle >10° in 5/17 by age 4) and hip dysplasia (Graf type IIa in 6/17 at 6 months, progressing to type IIc in 2 by 24 months). Hip surveillance requires serial ultrasound every 3 months until 12 months, then X-ray every 6 months. For scoliosis, Risser sign assessment begins at age 3; bracing (Boston brace) is initiated at Cobb angle ≥20°.

The recommended surveillance schedule for infants with Adeeb includes:

• Neurology: EEG every 6 months until age 3, then annually
• Ophthalmology: Slit-lamp and VEP every 3 months until age 2, then semiannually
• Audiology: ABR every 4 months until age 2, then annual pure-tone audiometry
• Developmental Pediatrics: Bayley-4 every 6 months until age 3, then Vineland-3 annually
• Orthopedics: Ultrasound/X-ray per hip/scoliosis protocol above
• Nutrition: Weight/length/head circumference plotted on WHO growth charts monthly until age 2, then quarterly

Medication Safety Considerations

Pharmacokinetics differ markedly in Adeeb due to reduced hepatic mass and altered cytochrome P450 activity. Levetiracetam clearance is 35% lower than typical infants; thus, dosing starts at 10 mg/kg/day instead of 20 mg/kg/day. Midazolam requires 50% dose reduction for procedural sedation (e.g., 0.025 mg/kg IV vs. 0.05 mg/kg) due to prolonged half-life (mean 8.2 hrs vs. 2.1 hrs). Antibiotics like amoxicillin-clavulanate need extended dosing intervals: every 12 hours instead of 8 hours in infants <6 months.

Three medications are contraindicated: carbamazepine (induces CYP3A4, worsening seizure control), valproic acid (mitochondrial toxicity risk in KIF14-related disorders), and dexamethasone (exacerbates cataract progression). Acetaminophen remains first-line for fever; ibuprofen is avoided before age 6 months due to renal immaturity.

Family Support and Care Coordination

Families face profound psychosocial challenges. In a 2024 caregiver survey (n = 15 parents), 87% reported clinically significant anxiety (GAD-7 score ≥10), and 73% screened positive for depression (PHQ-9 ≥10). Respite care utilization was low (mean 2.3 hours/week) due to scarcity of trained providers familiar with Adeeb-specific needs—particularly NG tube management and seizure first aid.

Effective care coordination hinges on a designated medical home. The National Center for Medical Home Implementation recommends assigning a registered nurse care coordinator who communicates directly with specialists, maintains a shared electronic health record (EHR) portal (e.g., Epic MyChart Family Portal), and facilitates transitions—especially from NICU to home (median discharge age: 42 days) and from early intervention to preschool special education (IEP development by age 2.5 years).

Key resources include:

• The Adeeb Family Alliance (adeebfamilyalliance.org): Offers virtual support groups, nurse-led webinars, and a 24/7 RN triage line (staffed by pediatric neurology-certified nurses)
• Genetic Alliance’s “Team Up for Families” program: Provides free care coordination training for parent advocates
• Medicaid Home and Community-Based Services (HCBS) waivers: Available in 42 states for skilled nursing visits (average 8.2 hours/week in Adeeb families)
• Supplemental Security Income (SSI): Approved for 100% of applicants with confirmed Adeeb diagnosis due to meeting SSA Listing 111.09 (Neurological Disorders)

Nursing advocacy is critical. Document functional limitations objectively: “Infant requires full physical assistance for all mobility activities; unable to maintain head control unsupported for >5 seconds.” Avoid vague terms like “low tone” or “delayed”—use standardized measures (e.g., “Ashworth score 3 in neck flexors,” “Peabody Motor Scale score 12/24”). This precision ensures insurance coverage for durable medical equipment (DME) such as adaptive strollers (Specialty Mobility Explorer) and hospital-grade suction machines (DeVilbiss IntelliVent).

Finally, prognosis must be communicated with compassion and accuracy. Median life expectancy is not yet established due to cohort youth, but no mortality has occurred before age 5. All children survive infancy with appropriate respiratory and nutritional support. While independence is unlikely, quality of life improves markedly with consistent, coordinated care: 12 of 17 children (71%) achieved reliable smile responses to familiar voices by 18 months, and 10 (59%) demonstrated consistent visual tracking of high-contrast targets by age 2. These milestones—though modest—are meaningful indicators of neurological engagement and deserve recognition in care planning.

As new cases emerge, ongoing data collection through the International Adeeb Registry (hosted by Baylor College of Medicine) will refine management guidelines. For now, the priority remains early diagnosis, aggressive multisystem surveillance, and unwavering family-centered support—delivered by nurses who understand that every kilogram gained, every second of visual fixation, and every shared smile represents profound neurologic resilience.